ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...

ICON plc’s ICLR focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added plus. The stock carries a Zacks Rank #2 (Buy) ...

CEO Steve Cutler introduced Barry Balfe as the newly appointed COO, highlighting his 20-year tenure at ICON and focus on strengthening strategic partnerships across the mid-size customer segment. The ...

BALLERUP, Denmark & DUBLIN--(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to ...

Earnings Call Insights: ICON Public Limited Company (NASDAQ:ICLR) Q4 2024 CEO Steve Cutler introduced Barry Balfe as the ...